LAUSR

The altered secretion or increased levels of released adipokine have been reported to contribute to several metabolic diseases, such as diabetes mellitus, obesity, and cardiovascular disorders. 1 Specific to diabetogenic adipokine, aprosin was recently reported to be the novel adipokine in diabetes mellitus cases, playing a potent role in inducing the production of hepatic glucose and influencing the appetite levels of the patients. In addition, a previous study mentioned that the polymorphism of ADIPOQ rs17366743 was one of the integrating common risk factors, besides CCL20 rs6749704, TCF7L2 rs114758349, and CCL2 rs1024611, associated with the prediction of type 2 diabetes on the Eurasian continent. 2 The study performed by Tangjittipokin et al was recently read and reviewed by our group. We do feel gratitude towards the authors of this article. 3 However, a few discussions provided here could, hopefully, be considered as insightful input in their future studies. The study was performed in order to investigate the association of ADIPOQ gene polymorphisms in pregnant women who could probably be diagnosed with gestational diabetes mellitus. 3 However, the polymorphisms of the ADIPOQ gene were detected from rs266729